Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia

PURPOSE: There are no comprehensive guidelines for the use of FDG PET in the following three clinical scenarios: (1) diagnostic work-up of patients with idiopathic Parkinson’s disease (PD) at risk of future cognitive decline, (2) discriminating idiopathic PD from progressive supranuclear palsy, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Walker, Zuzana, Gandolfo, Federica, Orini, Stefania, Garibotto, Valentina, Agosta, Federica, Arbizu, Javier, Bouwman, Femke, Drzezga, Alexander, Nestor, Peter, Boccardi, Marina, Altomare, Daniele, Festari, Cristina, Nobili, Flavio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061481/
https://www.ncbi.nlm.nih.gov/pubmed/29779045
http://dx.doi.org/10.1007/s00259-018-4031-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061481/
https://www.ncbi.nlm.nih.gov/pubmed/29779045
http://dx.doi.org/10.1007/s00259-018-4031-2

Ejemplares similares